February 8, 2022
National Center for Complementary and Integrative Health (NCCIH)
The purpose of this Notice is to inform potential applicants that a set of responses to Frequently Asked Questions (FAQs) regarding RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) has been posted at the following link:
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
HEAL Myofascial RFA Program Team